Amicus Therapeutics amicusrx.com


Public list: BIO 2016 (619) Smart Money VCs (6328) Pharma Startups (4734) Rare Diseases (230)

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.

Company (IPO / Went public)

Phone: 609-662-2000

Fax:

1 Cedar Brook Drive

Cranbury, 08512
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Amicus Therapeutics $221M Jun 1, 2007
Genaissance Pharmaceuticals $183.4M Sep 8, 2008
SHAR.DNA SpA $0M Feb 20, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Amicus Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors